A appetite depressant considered to produce less central nervous system disturbance than most drugs in this therapeutic category. It is also considered to be among the safest for patients with hypertension. (From AMA Drug Evaluations Annual, 1994, p2290)
Used in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction.
Ochsner Health System - Biospecimen, New Orleans, Louisiana, United States
LSU Clinical & Translational Research Center (CTRC - - LSUHSC-NO, New Orleans, Louisiana, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.